Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children

New England Journal of Medicine

Volumn 365, Issue 1, 2011, Pages 21-31

  Madhi, Shabir A ^a   Nachman, Sharon ^d   Violari, Avy ^a   Kim, Soyeon ^e   Cotton, Mark F ^b   Bobat, Raziya ^c   Jean Philippe, Patrick ^f   McSherry, George ^g   Mitchell, Charles ^h  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

^d STONY BROOK UNIVERSITY   (United States)

^e CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

^f Henry Jackson Foundation   (United States)

^g PENN STATE COLLEGE OF MEDICINE   (United States)

^h UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BCG VACCINE; ISONIAZID; PLACEBO;

ABNORMAL LABORATORY RESULT; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; EXPOSURE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PERINATAL PERIOD; PERIPHERAL NEUROPATHY; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 79960100289     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1011214     Document Type: Article

References (22)

1. Nunn P, Reid A, De Cock KM. Tuberculosis and HIV infection: the global setting. J Infect Dis 2007;196:Suppl 1:S5-S14. (Pubitemid 47206080)
2. Lawn SD, Bekker LG, Middelkoop K, Myer L, Wood R. Impact of HIV infection on the epidemiology of tuberculosis in a peri-urban community in South Africa: the need for age-specific interventions. Clin Infect Dis 2006;42:1040-7.
3. Middelkoop K, Bekker LG, Myer L, Dawson R, Wood R. Rates of tuberculosis transmission to children and adolescents in a community with a high prevalence of HIV infection among adults. Clin Infect Dis 2008;47:349-55. (Pubitemid 352009354)
4. Madhi SA, Huebner RE, Doedens L, Aduc T, Wesley D, Cooper PA. HIV-1 coinfection in children hospitalised with tuberculosis in South Africa. Int J Tuberc Lung Dis 2000;4:448-54. (Pubitemid 30256848)
5. Wood R, Johnstone-Robertson S, Uys P, et al. Tuberculosis transmission to young children in a South African community: modeling household and community infection risks. Clin Infect Dis 2010;51:401-8.
6. Marais BJ, Gie RP, Schaaf HS, et al. The natural history of childhood intrathoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis 2004;8:392-402. (Pubitemid 38624845)
7. Hesseling AC, Cotton MF, Jennings T, et al. High incidence of tuberculosis among HIV-infected infants: evidence from a South African population-based study highlights the need for improved tuberculosis control strategies. Clin Infect Dis 2009;48:108-14.
8. Madhi SA, Petersen K, Madhi A, Khoosal M, Klugman KP. Increased disease burden and antibiotic resistance of bacteria causing severe community-acquired lower respiratory tract infections in human immunodeficiency virus type 1-infected children. Clin Infect Dis 2000;31:170-6. (Pubitemid 32268959)
9. Chintu C, Mudenda V, Lucas S, et al. Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study. Lancet 2002; 360:985-90. (Pubitemid 35284110)
10. Ansari NA, Kombe AH, Kenyon TA, et al. Pathology and causes of death in a series of human immunodeficiency viruspositive and -negative pediatric referral hospital admissions in Botswana. Pediatr Infect Dis J 2003;22:43-7. (Pubitemid 36091777)
11. Hsu KH. Thirty years after isoniazid: its impact on tuberculosis in children and adolescents. JAMA 1984;251:1283-5. (Pubitemid 14195205)
12. Smieja MJ, Marchetti CA, Cook DJ, Smaill FM. Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst Rev 2000;2: CD001363.
13. Hsu KH. Isoniazid in the prevention and treatment of tuberculosis: a 20-year study of the effectiveness in children. JAMA 1974;229:528-33.
14. The South African National Tuberculosis Control Programme. Practical guidelines, 2004. (http://www.kznhealth.gov.za/chrp/documents/Guidelines/ Guidelines%20National/Tuberculosis/SA%20TB%20Guidelines%202004.pdf.)
15. Management of severe malnutrition: a manual for physicians and other senior health workers. Geneva: World Health Organization, 1999. (http://www.who.int/nutrition/publications/severemalnutrition/en/ manage-severe-malnutrition-eng.pdf.)
16. DAIDS/RSC. Toxicity tables, 2004. (http://www.ucdmc.ucdavis.edu/ clinicaltrials/documents/DAIDS-AE-GradingTable-FinalDec2004.pdf.)
17. Akolo C, Adetifa I, Shepperd S, Volmink J. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev 2010;1:CD000171.
18. Zar HJ, Cotton MF, Strauss S, et al. Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial. BMJ 2007;334:136.
19. Moore DP, Klugman KP, Madhi SA. Role of Streptococcus pneumoniae in hospitalization for acute community-acquired pneumonia associated with culture-confirmed Mycobacterium tuberculosis in children: a pneumococcal conjugate vaccine probe study. Pediatr Infect Dis J 2010;29: 1099-04.
20. Cotton MF, Wasserman E, Smit J, Whitelaw A, Zar HJ. High incidence of antimicrobial resistant organisms including extended spectrum beta-lactamase producing Enterobacteriaceae and methicillin-resistant Staphylococcus aureus in nasopharyngeal and blood isolates of HIV-infected children from Cape Town, South Africa. BMC Infect Dis 2008;8:40.
21. Marais BJ, Gie RP, Schaaf HS, Beyers N, Donald PR, Starke JR. Childhood pulmonary tuberculosis: old wisdom and new challenges. Am J Respir Crit Care Med 2006;173:1078-90. (Pubitemid 43726888)
22. Mount FW, Ferebee SH. Preventive effects of isoniazid in the treatment of primary tuberculosis in children. N Engl J Med 1961;265:713-21.